US Court Reopens 5,000 Fosamax Lawsuits

29.03.2017 - The US Third Circuit Court of Appeals in Philadelphia, Pennsylvania, has ruled that 5,000 lawsuits brought by patients taking Merck & Co.’s osteoporosis drug Fosamax (alendronate)...